IOVS AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Béliveau, A.
Right arrow Articles by Guérin, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Béliveau, A.
Right arrow Articles by Guérin, S. L.
(Investigative Ophthalmology and Visual Science. 2000;41:2363-2372.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Expression of Integrin {alpha}5ß1 and MMPs Associated with Epithelioid Morphology and Malignancy of Uveal Melanoma

Alain Béliveau1, Mélanie Bérubé2, Alain Rousseau3, Guy Pelletier2 and Sylvain L. Guérin1

1 From the Oncology and Molecular Endocrinology Research Center, 2 Unit of Rheumatology and Immunology, and 3 Unit of Ophthalmology, Centre Hospitalier Universitaire de Québec and Laval University, Ste-Foy, Québec, Canada.

PURPOSE. Altered expression of the {alpha}5ß1 integrin and matrix metalloproteinases (MMPs) is recognized as a hallmark of invasive tumor cells. The purpose of the present study was to investigate the expression of integrin subunit {alpha}5, its corresponding ligand fibronectin (FN), and the expression pattern for MMPs in four highly proliferative human choroidal melanomas (TP17, TP31, SP8.0, and SP6.5) to evaluate whether any correlation can be established between these markers and cell tumorigenicity.

METHODS. Cell tumorigenicity was evaluated by subcutaneous injection of uveal melanoma cell lines in immunodeficient nude mice. Anchorage dependency was evaluated by growth assays in soft agar. The invasive ability of each cell type was also determined using a modified Boyden chamber. Expression of both the {alpha}5 integrin subunit and FN was determined at the mRNA level by RT-PCR. The protein level (for {alpha}5) was determined by flow cytometry and inhibition of adhesion assays by using an antibody directed against the {alpha}5 subunit. Expression of MMPs was determined by standard gelatin zymography.

RESULTS. Assays in nude mice provided evidence that the cell lines possess a range of tumorigenic ability of TP17>TP31>SP8.0>SP6.5. Antibody inhibition of cell adhesion and flow cytometry demonstrated that TP17 cells have no detectable membrane-bound {alpha}5ß1, whereas low levels are found in primary cultured melanocytes, as well as in SP6.5, SP8.0, and TP31 cells. RT-PCR analyses provided evidence that both FN and {alpha}5 expression may be regulated at the transcriptional level. Gelatin zymography revealed that all cell lines, as well as normal melanocytes, express MMP-2 at varying levels but that only the highly invasive TP17 cell line secretes a distinctive MMP with a high molecular weight of 117 kDa.

CONCLUSIONS. Among the four melanoma cell lines selected for the completion of this study, TP17 exhibited the most aggressive phenotype, which also correlated with the mostly epithelioid morphology of these cells. The cell morphology of the TP17 cell line could be related to the loss of {alpha}5ß1, whereas its invasive properties are more likely related to the expression of the 117-kDa MMP.




This article has been cited by other articles:


Home page
IOVSHome page
A. Beliveau, M. Berube, P. Carrier, C. Mercier, and S. L. Guerin
Tumorigenicity of the Mixed Spindle-Epithelioid SP6.5 and Epithelioid TP17 Uveal Melanoma Cell Lines Is Differentially Related to {alpha}5{beta}1 Integrin Expression
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3058 - 3065.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology